Ario Pharma Private Limited - Company Profile

It is a pharma private limited company based in Kalyan, Maharashtra, India, established in 2018.
2018 Kalyan, Maharashtra, India Active
Last Updated:
Access Report
About Ario Pharma Private Limited

Ario Pharma Private Limited, a active private limited company, was established on 08 March 2018 in Kalyan, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24304MH2018PTC306090. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Archis Vinayak Nerlikar (Director), Bhavna Archis Nerlikar (Director). Past directors included Jitendra Atmaram Samant. It holds ₹2.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at F-907, Orchid Wing-N, Codename Golden Dream,, Sector-10, Off. Taloja Midc Road,, Kalyan, Maharashtra, 421204.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304MH2018PTC306090

  • Registration Number

    306090

  • Incorporation Date

    08 March 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.20 M
  • Revenue Growth **** 346.88%
  • Profit Growth **** 290.18%
  • Ebitda **** 379.34%
  • Net Worth 296.45%
  • Total Assets **** 89.48%
Company report

Ario Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ario Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ario Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Archis Vinayak Nerlikar Director 08 Mar 2018 Current
Bhavna Archis Nerlikar Director 27 Mar 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Mar 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ario Pharma.

Ario Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 346.88% increase. The company also saw a substantial improvement in profitability, with a 290.18% increase in profit. The company's net worth Soared by an impressive increase of 296.45%.

Ario Pharma revenue growth over time
Ario Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 346.88%
*******
*******
*******
*******
Revenue from Operations
*******
 346.88%
*******
*******
*******
*******
Total Assets
*******
 89.48%
*******
*******
*******
*******
Profit or Loss
*******
 290.18%
*******
*******
*******
*******
Net Worth
*******
 296.45%
*******
*******
*******
*******
EBITDA
*******
 379.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ario Pharma?

In 2022, Ario Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,200,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Tata Capital Housing Finance Limited : 0.22 Cr
Latest Charge Details
Date Lender Amount Status
09 Jun 2022 Tata Capital Housing Finance Limited ₹2.20 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Ario Pharma?

Unlock and access historical data on people associated with Ario Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ario Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ario Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ario Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Ario Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Ario Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii. was documented.

  • Charges

    A charge with Tata Capital Housing Finance Limited amounted to Rs. 2.20 M with Charge ID 100593552 was registered on 09 Jun 2022. was recorded as a recent event.

  • Director Appointment

    The activity Bhavna Archis Nerlikar was appointed as a Director was appointed as a Director on 27 Mar 2020 & has been associated with this company since 5 years 11 months . was completed.

  • Director Appointment

    The activity Archis Vinayak Nerlikar was appointed as a Director was appointed as a Director on 08 Mar 2018 & has been associated with this company since 7 years 11 months . was completed.

  • Company Incorporation

    The activity Ario Pharma Private Limited was registered on 08 Mar 2018 with Roc Mumbai Ii & aged 7 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ario Pharma Private Limited?

The CIN of Ario Pharma Private Limited is U24304MH2018PTC306090.

Where is Ario Pharma Private Limited headquartered?

Ario Pharma Private Limited is headquartered at F-907, Orchid Wing-N, Codename Golden Dream,, Sector-10, Off. Taloja Midc Road,, Kalyan, Maharashtra, 421204.

When was Ario Pharma Private Limited incorporated?

Ario Pharma Private Limited was incorporated on 08 March 2018.

Who are the current directors of Ario Pharma Private Limited?

The current directors of Ario Pharma Private Limited are

What is the primary industry of Ario Pharma Private Limited?

The primary industry of Ario Pharma Private Limited is Trade.

Is Ario Pharma Private Limited a listed company?

Ario Pharma Private Limited is unlisted.

What is the capital structure of Ario Pharma Private Limited?

The authorized capital of Ario Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Ario Pharma Private Limited?

The compliance status of Ario Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available